Browsing by Subject "Cardiac & Cardiovascular Systems"
Now showing items 1-10 of 10
-
Changes in Medical Therapy and Lifestyle After Anatomical Versus Functional Testing for Coronary Artery Disease: The PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of Chest Pain)
(CIRCULATION, 2015-11-10)Introduction: Diagnostic testing may represent a “teachable moment” for patients newly presenting with symptoms suggestive of CAD and requiring further evaluation, and may influence risk factor management, independent of ... -
Effect of Patent Foramen Ovale in Patients With Pulmonary Hypertension.
(The American journal of cardiology, 2018-08)Septostomy reduces right ventricular (RV) workload at the expense of hypoxemia in patients with advanced pulmonary hypertension (PH). A patent foramen ovale (PFO) may serve as a "natural" septostomy, but the incidence and ... -
Executive Summary: Heart Disease and Stroke Statistics—2011 Update
(Circulation, 2011-02) -
Finding Means to Fulfill the Societal and Academic Imperative for Open Data Access and Sharing.
(JAMA cardiology, 2018-09) -
Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial.
(JAMA cardiology, 2019-01)Importance:Patients with peripheral artery disease (PAD) are at high risk for myocardial infarction (MI). Objective:To characterize the incidence and types of MI in a PAD population, identify factors associated with MI, ... -
More Frequent Self-Testing of Prothrombin Time Results in Improved Time in Target Range
(CIRCULATION, 2012-11-20) -
Overdue to understand anticoagulation in pulmonary arterial hypertension.
(Pulmonary circulation, 2018-01) -
P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes.
(JAMA cardiology, 2019-07)Importance:Physician behavior in response to knowledge of a patient's CYP2C19 clopidogrel metabolizer status is unknown. Objective:To investigate the association of mandatory reporting of CYP2C19 pharmacogenomic testing, ... -
Transcatheter closure of patent foramen ovale following cryptogenic stroke: An updated meta-analysis of randomized controlled trials.
(American heart journal, 2018-05)Transcatheter closure of patent foramen ovale (PFO) after cryptogenic stroke has long been a contentious issue. Herein, we pool aggregate data examining safety and efficacy of transcatheter closure of PFO compared with medical ...
